Zobrazeno 1 - 10
of 30
pro vyhledávání: '"D A, Podoloff"'
Publikováno v:
Radiology. 198:614-616
Publikováno v:
Pharmaceutical research. 16(5)
The assessment of tumor hypoxia by imaging modality prior to radiation therapy would provide a rational means of selecting patients for treatment with radiosensitizers or bioreductive drugs. This study aimed to develop a 99mTc-labeled metronidazole (
Autor:
D J, Macey, E J, Grant, L, Kasi, M G, Rosenblum, H Z, Zhang, R L, Katz, P T, Rieger, D, LeBherz, M, South, J W, Greiner, J, Schlom, D A, Podoloff, J L, Murray
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(9)
Preclinical studies have demonstrated that recombinant IFN-alpha (rIFN-alpha) can enhance the tumor associated glycoprotein 72 (TAG-72) on tumors. To determine whether rIFN-alpha could enhance TAG-72 expression in vivo in patients, 15 women with brea
Autor:
T, Inoue, E E, Kim, F C, Wong, D J, Yang, P, Bassa, W H, Wong, M, Korkmaz, W, Tansey, K, Hicks, D A, Podoloff
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(9)
Two commonly used tumor-seeking agents for PET are 2-deoxy-2-18F-fluoro-D-glucose (FDG) and L-methyl-11C-methionine (Met). This study compared FDG and Met in detecting residual or recurrent malignant tumors in the same patients.Thirty-four lesions in
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(9)
We compared the diagnostic accuracy of [18F]FDG PET and 99mTc-MIBI SPECT in musculoskeletal sarcomas.Forty-eight patients with clinically suspected recurrent or residual musculoskeletal sarcomas were examined with both FDG-PET and MIBI-SPECT within 2
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 36(10)
Two major obstacles in the development of improved methods for more accurate dose estimates for radioimmunotherapy have been the difficulty in obtaining an accurate patient-specific three-dimensional activity map in vivo and calculating the resulting
Autor:
D A, Podoloff
Publikováno v:
Hematology/oncology clinics of North America. 9(3)
Images were interpreted and correlated with contemporaneous CT and/or MR imaging studies. Visual qualitative analysis of all images was performed by two or more nuclear medicine physicians expert in reading these studies. Tracer uptake was graded by
Autor:
T, Inoue, E E, Kim, R, Komaki, F C, Wong, P, Bassa, W H, Wong, D J, Yang, K, Endo, D A, Podoloff
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 36(5)
We investigated the diagnostic accuracy of FDG-PET in the detection of recurrent lung cancer.Thirty-nine lesions in 38 patients with clinically suspected recurrent or residual lung cancer were studied with PET. All PET images were visually interprete
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 36(2)
Breast involvement by malignant lymphoma either as a primary site or as a secondary site from lymphoma elsewhere is rare. Primary breast lymphoma (PBL) accounts for only a small percentage of total malignant lymphoma involving the breast. The inciden
Autor:
J L, Murray, D J, Macey, L P, Kasi, P, Rieger, J, Cunningham, V, Bhadkamkar, H Z, Zhang, J, Schlom, M G, Rosenblum, D A, Podoloff
Publikováno v:
Cancer. 73
Radiolabeled CC49, a second generation high affinity monoclonal antibody (MoAb) reactive with tumor-associated glycoprotein 72 (TAG72) has undergone previous Phase I testing in patients with colon cancer. Based on this report, the authors treated 15